These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37455693)

  • 1. Dasatinib-Induced Chylothorax Beyond 5 Years of Treatment: Is There Actually Any Limit?
    Garcia-Zamalloa A; Basauri B; Urcelay G; Sainz A
    Eur J Case Rep Intern Med; 2023; 10(7):003921. PubMed ID: 37455693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib.
    Bradt N; Olbrechts F; Alexander P; Salembier A
    Eur J Case Rep Intern Med; 2022; 9(10):003601. PubMed ID: 36415836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib-induced chylothorax: report of a case and review of the literature.
    Chen B; Wu Z; Wang Q; Li W; Cheng D
    Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
    Ng IK; Ruparel M; Chan EH; Khoo KL
    J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
    Hsu CC; Hsu JF; Wu KL
    Respirol Case Rep; 2021 Jun; 9(6):e00753. PubMed ID: 33976882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
    Liu Q; Fu J; Zhang A
    Transl Cancer Res; 2023 Jan; 12(1):194-200. PubMed ID: 36760377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib-Induced Chylothorax: A Clinical Laboratory's Perspective.
    Martínez RJG; Gea CS; Martin-Riera V; Ruiz ARG; Barzanti RP; Ferrer-Costa R; Ramirez-Serra C
    EJIFCC; 2023 Apr; 34(1):76-80. PubMed ID: 37124659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature review.
    Paul T; Ellahie AY; Almohtasib YS; Sinha U; El Omri H
    EJHaem; 2021 Aug; 2(3):545-550. PubMed ID: 35844702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib-induced Chylothorax in Chronic Myeloid Leukemia.
    Alqattan Y; Ali S; Almohammad R; Kayali N; Alhuraiji A
    Gulf J Oncolog; 2022 Sep; 1(40):74-77. PubMed ID: 36448074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
    Kelly RL; Bae JY; D'Annunzio S; Montanari F
    Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
    Yang L; Lu N; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia.
    Makimoto G; Misawa M; Maeda Y; Kiura K
    Respir Med Case Rep; 2022; 37():101662. PubMed ID: 35585905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan".
    Sasaki H; Kimizuka Y; Ogata H; Okada Y; Ota S; Sano T; Watanabe C; Maki Y; Yamamoto T; Tagami Y; Miyata J; Hayashi N; Fujikura Y; Kawana A
    Intern Med; 2019 Nov; 58(21):3139-3141. PubMed ID: 31292394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib.
    Nasir SA; Calavia Liano H; Manfredi C
    Cureus; 2022 Aug; 14(8):e27778. PubMed ID: 36106302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib-related chylothorax.
    Huang YM; Wang CH; Huang JS; Yeh KY; Lai CH; Wu TH; Chang PH; Chang PH; Chang YS; Lan YJ
    Turk J Haematol; 2015 Mar; 32(1):68-72. PubMed ID: 25805678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylothorax: complication attributed to dasatinib use.
    Al-Abcha A; Iftikhar MH; Abu Rous F; Laird-Fick H
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31848139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib-induced pleural effusion: Chylothorax, an option to consider.
    Ferreiro L; San-José E; Suárez-Antelo J; Valdés L
    Ann Thorac Med; 2016; 11(4):289-293. PubMed ID: 27803756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
    Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
    J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
    Hickman K; Diaz E; Graham R; Adams R; Ngwube A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation.
    Alrubaye RR; Fadel CA; Adewunmi CY; Del Rio Lopez L
    Am J Case Rep; 2021 Aug; 22():e932711. PubMed ID: 34362863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.